Regenerative surgical implants company Tela Bio has brought in more than $2 million in investments, according to a recent U.S. Securities and Exchange Commission filing.
The Malvern, Pa.–based company had sought to raise a total $3 million, according to the SEC Form D filed Dec. 4.
The company said a month later that Checkmate Capital, a strategic investment group based in Los Angeles and Beijing, had agreed to an initial Series B investment.
Tela Bio’s OviTex reinforced bioscaffolds products are meant for hernia repair and abdominal wall reconstruction. They compbine polymer and biologic materials in what the company describes as a uniquely embroidered construction.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.